Letter on: "Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population".
作者信息
Toubasi Ahmad Amjed
机构信息
Faculty of Medicine, the University of Jordan, Amman 11942, Jordan.
出版信息
Schizophr Res. 2021 Jul;233:97-98. doi: 10.1016/j.schres.2021.06.036. Epub 2021 Jun 26.
Abstract
摘要
相似文献
1
Letter on: "Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population".关于“接受抗精神病药物治疗的严重精神障碍患者感染 SARS-CoV-2 的风险较低：一项针对西班牙代表性人群的回顾性流行病学研究”的信函
Schizophr Res. 2021 Jul;233:97-98. doi: 10.1016/j.schres.2021.06.036. Epub 2021 Jun 26.
2
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population.接受抗精神病药物治疗的严重精神障碍患者感染SARS-CoV2的风险较低：一项针对西班牙代表性人群的回顾性流行病学研究。
Schizophr Res. 2021 Mar;229:53-54. doi: 10.1016/j.schres.2021.02.002. Epub 2021 Feb 19.
3
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.在纽约州一家精神科医院系统中，长期住院的严重精神疾病患者使用精神药物与 COVID-19 感染风险之间的关联。
JAMA Netw Open. 2022 May 2;5(5):e2210743. doi: 10.1001/jamanetworkopen.2022.10743.
4
Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19.抗精神病药物使用与 COVID-19 老年精神病门诊患者临床结局相关的死亡率。
PLoS One. 2021 Oct 21;16(10):e0258916. doi: 10.1371/journal.pone.0258916. eCollection 2021.
5
An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.对正在接受严重精神疾病治疗的患者使用抗精神病药物对SARS-CoV-2可能产生的保护作用的分析。
Schizophr Res. 2021 Jul;233:99-100. doi: 10.1016/j.schres.2021.06.019. Epub 2021 Jun 23.
6
Decline In New Starts Of Psychotropic Medications During The COVID-19 Pandemic.精神类药物在 COVID-19 大流行期间新处方数量下降。
Health Aff (Millwood). 2021 Jun;40(6):904-909. doi: 10.1377/hlthaff.2021.00028.
7
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
8
Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study.精神障碍与 SARS-CoV-2 感染及严重健康结局的关联：全国队列研究。
Br J Psychiatry. 2021 Jun;218(6):344-351. doi: 10.1192/bjp.2020.251.
9
Letter to "C-reactive protein level predicts need for medical intervention in pregnant women with SARS-CoV2 infection: A retrospective study".致《C反应蛋白水平预测新冠病毒感染孕妇的医学干预需求：一项回顾性研究》
J Obstet Gynaecol Res. 2022 May;48(5):1285-1286. doi: 10.1111/jog.15207. Epub 2022 Mar 10.
10
Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al.致编辑的信：关于高某等人对无症状严重急性呼吸综合征冠状病毒2（SARS-CoV-2）携带者传染性的研究
Respir Med. 2022 Jan;191:106061. doi: 10.1016/j.rmed.2020.106061. Epub 2020 Jun 9.
引用本文的文献
1
An overall protective effect of antipsychotic drugs against COVID-19 seems implausible.抗精神病药物对新冠病毒疾病具有全面保护作用，这似乎不太可信。
Schizophr Res. 2022 May;243:486-488. doi: 10.1016/j.schres.2021.12.020. Epub 2021 Dec 22.
本文引用的文献
1
Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19.肝脂肪变性而非潜在肥胖增加了COVID-19感染和住院风险。
Front Med (Lausanne). 2021 Mar 29;8:636637. doi: 10.3389/fmed.2021.636637. eCollection 2021.
2
Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study.高血压及相关合并症作为新冠病毒肺炎住院和严重程度的潜在风险因素：一项基于人群的前瞻性队列研究
J Clin Med. 2021 Mar 12;10(6):1194. doi: 10.3390/jcm10061194.
3
A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders.一项荟萃分析：精神障碍患者 COVID-19 的死亡率和严重程度。
Psychiatry Res. 2021 May;299:113856. doi: 10.1016/j.psychres.2021.113856. Epub 2021 Mar 3.
4
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population.接受抗精神病药物治疗的严重精神障碍患者感染SARS-CoV2的风险较低：一项针对西班牙代表性人群的回顾性流行病学研究。
Schizophr Res. 2021 Mar;229:53-54. doi: 10.1016/j.schres.2021.02.002. Epub 2021 Feb 19.
5
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19.精神障碍与 COVID-19 患者死亡率的关联。
JAMA Psychiatry. 2021 Apr 1;78(4):380-386. doi: 10.1001/jamapsychiatry.2020.4442.
6
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.氟伏沙明对比安慰剂在伴有症状的 COVID-19 门诊患者中的临床恶化：一项随机临床试验。
JAMA. 2020 Dec 8;324(22):2292-2300. doi: 10.1001/jama.2020.22760.
7
Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States.精神障碍患者感染新冠病毒及死亡风险增加：来自美国电子健康记录的分析
World Psychiatry. 2021 Feb;20(1):124-130. doi: 10.1002/wps.20806. Epub 2020 Oct 7.
8
Drug Interactions of Psychiatric and COVID-19 Medications.精神科药物与新冠治疗药物的药物相互作用
Basic Clin Neurosci. 2020 Mar-Apr;11(2):185-200. doi: 10.32598/bcn.11.covid19.2500.1. Epub 2020 Apr 27.
9
Depression and explicit requests for euthanasia in end-of-life cancer patients in primary care in the Netherlands: a longitudinal, prospective study.荷兰初级保健中终末期癌症患者的抑郁与明确安乐死请求：一项纵向、前瞻性研究。
Fam Pract. 2011 Aug;28(4):393-9. doi: 10.1093/fampra/cmr006. Epub 2011 Mar 18.
Zotero 插件